Royster R L, Keeler D K, Haisty W K, Johnston W E, Prough D S
Department of Anesthesia, Wake Forest University Medical Center, Winston-Salem, NC 27103.
Anesth Analg. 1988 Jan;67(1):15-20.
The effects of fentanyl, both alone and in combination with pancuronium bromide or succinylcholine, on atrioventricular (AV) node and ventricular conduction times and refractory periods were studied. Twenty-four pentobarbital-anesthetized dogs were instrumented both with an intraaortic catheter to measure cardiac conduction times and, through a thoracotomy, with atrial and ventricular epicardial pacing electrodes to provide premature stimulation that would allow measurement of atrial and ventricular refractoriness. Fentanyl prolonged the RR interval in both low- (100 micrograms/kg) and high-dose (400 micrograms/kg) groups by 26 and 45%, respectively, and prolonged AV node conduction time by 28 and 25%, respectively. During atrial pacing at a rate sufficient to capture the atria, AV node conduction time lengthened in the low- and high-dose groups by 27 and 25%, respectively. Fentanyl also significantly lengthened AV node effective and functional refractory periods and ventricular effective refractory periods in both groups. Pancuronium (0.1 mg/kg) administered after fentanyl shortened RR intervals in the low- and high-dose groups by 14 and 22%, respectively, and shortened AV conduction times by 18 and 20%, respectively, but did not restore all values to baseline. Pancuronium significantly shortened AV node refractory periods in the low-dose but not the high-dose group. When administered after fentanyl, succinylcholine (2 mg/kg) significantly shortened the RR interval in the low- and high-dose groups by 14 and 12%, respectively. Succinylcholine shortened AV node conduction slightly but without significance and had no effect on cardiac refractoriness. His-Purkinje conduction remained unaffected by any drug intervention. These data demonstrate that fentanyl depresses cardiac conduction; subsequent administration of pancuronium and succinylcholine partially reverses this effect.
研究了芬太尼单独使用以及与潘库溴铵或琥珀酰胆碱联合使用对房室(AV)结、心室传导时间和不应期的影响。24只戊巴比妥麻醉的犬,通过插入主动脉内导管来测量心脏传导时间,并通过开胸手术植入心房和心室心外膜起搏电极,以提供过早刺激,从而能够测量心房和心室的不应期。芬太尼使低剂量组(100微克/千克)和高剂量组(400微克/千克)的RR间期分别延长了26%和45%,使AV结传导时间分别延长了28%和25%。在以足以捕获心房的频率进行心房起搏时,低剂量组和高剂量组的AV结传导时间分别延长了27%和25%。芬太尼还显著延长了两组的AV结有效和功能不应期以及心室有效不应期。在芬太尼给药后给予潘库溴铵(0.1毫克/千克),低剂量组和高剂量组的RR间期分别缩短了14%和22%,AV传导时间分别缩短了18%和20%,但并未使所有值恢复到基线水平。潘库溴铵显著缩短了低剂量组而非高剂量组的AV结不应期。在芬太尼给药后给予琥珀酰胆碱(2毫克/千克),低剂量组和高剂量组的RR间期分别显著缩短了14%和12%。琥珀酰胆碱使AV结传导略有缩短但无统计学意义,且对心脏不应期无影响。希氏-浦肯野传导不受任何药物干预的影响。这些数据表明,芬太尼会抑制心脏传导;随后给予潘库溴铵和琥珀酰胆碱可部分逆转这种效应。